Nitrazepam Bristol Laboratories (Nitrazepam)

Nitrazepam binds to the benzodiazepine site on the GABA‑A receptor complex, enhancing the inhibitory action of the neurotransmitter GABA. This increases chloride ion influx into neurons, causing hyperpolarisation and reduced neuronal excitability, which results in sedative, anxiolytic, anticonvulsant, and muscle‑relaxant effects.

The appropriate dose of nitrazepam is determined by the prescribing clinician based on the patient’s age, medical condition, response to therapy and any concomitant medications. Dosage regimens are individualized and should follow the prescriber’s instructions on the prescription label.

Safety data for nitrazepam in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitrazepam shares the core mechanism of GABA‑A modulation with other benzodiazepines but has a relatively long half‑life, which can provide sustained therapeutic effect for insomnia and seizure control. Compared with shorter‑acting agents, it may have a higher risk of residual daytime sedation, making dose timing important.

Nitrazepam tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect from moisture, heat and direct sunlight, and keep out of reach of children.

Nitrazepam is taken orally, usually as a whole tablet with a glass of water. The exact timing—often before bedtime for insomnia—should follow the prescriber’s directions. Swallow the tablet whole; do not crush, chew, or split unless specifically instructed.

Serious risks include respiratory depression, especially when combined with other central nervous system depressants, development of physical dependence and withdrawal syndrome, severe allergic reactions, and paradoxical reactions such as increased agitation or aggression. Patients should seek immediate medical attention if these symptoms occur.

Nitrazepam is contraindicated in individuals with known hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow‑angle glaucoma, and in patients who are currently abusing alcohol or other depressants. Caution is also advised for those with severe hepatic impairment or a history of substance dependence.